APCI Applauds Governor, Legislature for Passage of SB 252
SB 252 was crafted to bring long-overdue transparency to prescription drug pricing, ensure fair reimbursement for pharmacies, and rein in abusive PBM practices that have contributed to rising drug costs and the closure of community pharmacies across the state.
"We applaud
SB 252 ties independent pharmacy reimbursement in commercial insurance plans to Alabama Actual Acquisition Cost (AAC)—a transparent, state-maintained pricing benchmark already used by Alabama Medicaid. The legislation protects patient access to local pharmacies and ensures that dispensing fees are paid by PBMs and insurers—and are not passed on to patients.
The bill passed both legislative chambers without opposition, with a 33-0 vote in the Senate and a 102-0 vote in the House. Such bipartisanship is rare in the
APCI also applauds the tireless work of its members and partners—including the Alabama Pharmacy Association (APA) and the Alabama Independent Pharmacy Alliance (AIPA)—for their persistent advocacy throughout the 2025 legislative session.
"This victory would not have been possible without the coordinated, grassroots efforts of independent pharmacists across the state who stood up, spoke out, and stayed engaged," Hamrick added. "Together, we've made it clear that
SB 252 has earned the support of healthcare providers, small business owners, patient advocates, and lawmakers from across the political spectrum. Passage of the bill puts
About APCI
American Pharmacy Cooperative, Inc. (APCI) is a member-owned cooperative representing independent pharmacies in 31 states, including hundreds in
View original content to download multimedia:https://www.prnewswire.com/news-releases/apci-applauds-governor-legislature-for-passage-of-sb-252-302429307.html
SOURCE American Pharmacy Cooperative, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Interlune Produces Pure Helium-3 from Domestic Helium Using Novel Cryogenic Technology
- ARUP Launches First Clinical Spectral Flow Cytometry Assay for MRD Assessment in Multiple Myeloma
- MCCATHERN, SHOKOUHI, EVANS LAUNCHES DEBUT PODCAST, "THE LAW BEHIND THE HEADLINES"
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share